for Patients or Caregivers
 
 
for Patients or Caregivers- - - - -Understanding Severe Primary IGFD - - - - -Why Increlex is a Breakthrough Therapy- - - - -About Increlex- - - - -Kids Want to Know Q&A- - - - -Full Prescribing Information- - - - -Medical Information- - - - -


for Healthcare Professionalsfor TerciCare Information
How this Condition is Diagnosed

Your doctor has measured your child, asked questions about family history, and ruled out the prospect of other diseases and conditions that can affect the stature of a child.


It is believed that approximately 6,000 children in the United States have severe Primary IGFD.3


Equally important are tests to determine levels of growth hormone and levels of IGF-1 in the body. If your childs height is significantly different from other children, if IGF-1 levels are abnormally low, and if growth hormone levels are normal or elevated, your doctor may diagnosis the condition as severe Primary IGFD. 2

While "severe" may sound intimidating, its important to remember that this term is used primarily by doctors for classification purposes. Remember that "severe" does not eliminate a bright, new prospect for help and hope.



2. Increlex [package insert]. Brisbane, Calif: Tercica; 2005.

3. Data on File. Brisbane, Calif: Tercica; 2005.

4. Isaksson O. GH, IGF-1, and growth. J Pediatr Endocrinol Metab. 2004:17(suppl 4);1321-1326.



Email this page Email the Increlex website to a friend      Print this page Print this page


 
 
Important Safety Information   |   Home   |   Site Map Tercica